Detalles de la búsqueda
1.
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors.
Pharmacol Res
; 192: 106782, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37127213
2.
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib.
J Cell Mol Med
; 24(1): 465-475, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31758648
3.
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Pharmacol Res
; 159: 104957, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32485280
4.
Role of VEGFs/VEGFR-1 Signaling and its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models.
Int J Mol Sci
; 21(4)2020 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32085654
5.
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.
J Pharmacol Exp Ther
; 364(1): 77-86, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29025978
6.
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research.
J Cancer
; 15(1): 1-19, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164270
7.
NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.
J Transl Med
; 10: 252, 2012 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23259744
8.
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor.
Cancers (Basel)
; 14(22)2022 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428669
9.
Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug.
Biomolecules
; 12(2)2022 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35204815
10.
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose.
Cell Biosci
; 12(1): 108, 2022 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35842713
11.
Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma.
Cancers (Basel)
; 12(11)2020 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33212945
12.
Poly(ADP-ribose) polymerase inhibitor olaparib hampers placental growth factor-driven activation of myelomonocytic cells.
Oncol Rep
; 39(5): 2261-2269, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29512738
13.
Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.
Oncotarget
; 8(40): 66833-66848, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28977999
14.
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
J Exp Clin Cancer Res
; 36(1): 106, 2017 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28797294
15.
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
Oncotarget
; 7(45): 72868-72885, 2016 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27655684
16.
Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
Nutrients
; 8(11)2016 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27879653
17.
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
Biochem Pharmacol
; 95(1): 16-27, 2015 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25795251
Resultados
1 -
17
de 17
1
Próxima >
>>